33rd Scientific Meeting of the Dutch Society of Nephrology  by unknown
Kidney International, Vol. 34 (1988), pp. 556—562
Abstracts
33rd Scientific Meeting of the Dutch Society of Nephrology
March 26, 1988
Ghent, Belgium
Anti-laminin autoantibodies and mercury-induced membranous gb-
merubopathy in the UZE rat. J. Aten, J.A. Brujjn, A. Veninga, K de
Heer, J.J. Weening, Department of Pathology, University of Leiden,
The Netherlands. HgC12 can induce a transient autoimmune syndrome
in rats, with development of glomerulonephritis (ON) and proteinuria
(P). The pathogenesis of ON was studied in DZB rats, given HgCI2 s.c.
at days 1, 3, 5, 7 and 9. Transient nephrotic range P occurred in 53% of
the animals, reaching a maximum at day 17. Direct immunofluorescence
(IF) showed development of a granular pattern of 1g01 and IgG2,, along
the OEM from day 10 in all rats and C9 only in rats with P. Electron
microscopy revealed subepithelial aggregates. Antibodies, eluted from
day 15 glomeruli, bound in a linear pattern along OEM and TBM in
normal kidney, when studied by indirect IF. With indirect immuno-
electromicroscopy, binding was found to be concentrated at the cell
membranes of glomerular and tubular epithelium adjacent to the OEM
and TBM, respectively; the OEM and TBM themselves were faintly
stained. Eluates and sera from day 15 were reactive against collagenase-
digested rat GBM, and, more specifically, against laminin, but did not
bind to collagen IV, fibronectin, heparan sulfate proteoglycans or
immunopurified gp9O and gp330, as determined by ELISA. I.v. transfer
of day 15 eluates to naive recipients induced variable degrees of F, up
to 100 mg/24 hr after 5 days. At day 5 after injection, direct IF showed
binding of 1gO and 1g02,, in a fine granular pattern. Eluates could
inhibit attachment of cultured glomerular epithelial cells in vitro and
induce cytotoxicity, as shown by increased release of carboxyfluores-
cein. A pathogenetic role is hypothesized in this model for autoanti-
bodies with reactivity against glomerular epithelium, involving speci-
ficity for a cell-binding epitope on the laminin molecule.
Blunted natriuretic response to ANF in liver cirrhosis. J.J. Beutler, J.
van Hattum, CA. Gaillard, A.J. Rabelink, HA. Koomans, E.J.
Dorhout Mees, Department of Nephrology and Gastroenterology,
University Hospital Utrecht, The Netherlands. To further examine
whether overflow or underfill is involved in renal sodium retention in
liver cirrhosis, we studied the natriuretic response to ANF (100 jig
bolus i.v.) during water-loading and lithium clearance (CLI) in 9 patients
with cirrhosis (C) with portal hypertension but without ascites, and in 2
patients with ascites. These patients had a 60 to 150 mmol sodium diet
and were compared to 3 groups of healthy controls on a 20 (N = 10), 100
(N = 12) and 200 (N = 10) mmol sodium diet. Blood pressure (EP) was
low only in the two patients with ascites. The most prominent feature of
our findings was that the natriuretic response was impaired in the
patients without and with ascites. In the former group and in the healthy
controls the increase in Na-excretion was correlated to baseline excre-
tion (r = 0.90, P < 0.0001 and r = 0.75, P c 0.0001, respectively), but
even taking differences in baseline excretions into account, the natri-
uretic response was blunted in the patients (P C 0.001). The rise in
fractional lithium excretion (FELl) and distal delivery estimated from
the free water clearance was also blunted in cirrhotics, Plasma ANF
and its rise after ANF-injection was not different in the patients and in
controls. We conclude that the natriuretic response to ANF is blunted
in a subset (7) of cirrhotics with portal hypertension even without
ascites. This is in concert with the overflow theory, suggesting that
sodium retention in cirrhosis is due to a renal defect, at least initially.
Patients
C C
Healthy subjects
20 100 200
—ascites +ascites mmol Na mmol Na mmol Na
BP 131/81 108/68 116/81 111/77 115/82
mmHg
C1mlImin 109±5 78±24 111±7 111±6 116±8
C1± 115±6 84±30 123±8 122±7 131±8
ANF
UNaV 161±39 108±18 47±11 130±18 226±26
jimol/min
UNRV+ 286±78 134±60 177±23 457±95 899±76
ANF
FENa % 1.1 0.3 1.1 0.2 0.3 0,05 0.8 0.1 1.5 0.4
FENa 1.9 0.5 1.1 0.1 1.1 0.1 2.6 0.5 5.0 0.4
ANF
FELl % 28.6 1.9 28.7 6.6 26.8 1.6 31.2 2.0 29.0 1.3
FELl + 32.0 2.4 27.4 8.1 33.0 1.8 37.2 2.4 38.2 1.6
ANF
Mucormycosis (M) In 3 hemodialysis (11D) patients undergoing
deferoxamine (DFO) therapy. J. Boelaert, J. Verbanck, G. Van Roost,
M. Segaert, Brugge, Roeselare and Brussels, Belgium. M has been
reported up to Jan 1, 1988, in 19 HD patients from the USA. At least 18
of them received DFO for aluminum (N = 16) or iron (N = 2) overload.
We report 3 Belgian patients (age 42, 49, 51 years), dialyzed for 6, 13
and 8 years, developing a disseminated and fatal M while under DFO
for aluminum overload. DFO was given at 2.2 and 2 to 4 g weekly for 4,
17, and 16 months, respectively. The diagnosis was made by pathology
in 2 cases and by culture (Rhizopus rhizopodiformis) in 1 case. Serum
ferritin prior to the tart of DFO was normal (212.50 and 290 ng/ml).
Two patients had prior evidence of liver dysfunction. An enquiry into
25 Belgian MD centers (1503 patients) showed that M had only occurred
in the 2 centers where 23% of the patients were on DFO, whereas no M
case had been observed in 23 centers where only 7% of the patients
were on DFO. The mechanism of the increased susceptibility for M of
ND patients treated by DFO is unknown. It has been hypothesized that
DFO could act as a siderophore to the Mucorales fungi, as is probably
the case with Yersinia, However, several differences distinguish infec-
tions by these microorganisms. All the 11 MD patients reported up to
now with Y. enterolitica bacteremia and in whom the iron status is
known, had iron overload and only 4 of ii were receiving DFO; in
contrast, all the ND patients reported with M (with I possible excep-
tion) were treated with DFO, but their iron status was highly variable,
Practically, the indication for DFO therapy in HD patients should be
very strict.
Effect of thiazides with and without carbo-anhydrase Inhibiting activity
on free water and lithium clearance (CLi). W.H. Boer, H.A. Koomans,
E.J. Dorhout Mees, Department of Nephrology, Utrecht, The Nether-
lands. Assuming that Li is reabsorbed proportionally to H20 and Na in,
556
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but not beyond the proximal tubules, CLI has been advanced as an index
of distal Na and H20 delivery. In support of this hypothesis, thiazides
acting exclusively in the distal tubule (e.g. bendroflumethiazide,
BFMT) should not affect CLI, whereas thiazides also affecting proximal
Na transport through carbo-anhydrase (CA) inhibition (e.g. chlorothi-
azide, CTZ) should increase CLI. We performed clearance studies
(maximum water diuresis, correction of Na losses) before and after
BFMT (15 mg p.o.) and CTZ (250 mg iv.) in 6 healthy humans.
Control BFMT Control CTZ
GFR mI/mm 108 20 109 20 110 12 95 12
CLI/GFR % 25.8 4.7 23.3 3.0 25.0 5.3 36.3 57a
Vmax/ % 10.6 2.1 9.5 1.5 9.1 2.2 15.4 2.8a
GFR
CHO/FR % 8.6 1.8 5.8 l.la 7.1 1.8 8.1 2.l
CNa/
GFR % 0.3 0.3 1.9 0.8 0.1 0.1 4.2 o.5
Ub,, V jtmol/min 19 13 26 18 33 24 248 62
Abbreviations are: Vmax, maximum urine flow, CH2O, maximum free
water clearance
a P < 0.05 vs. control
A rise in CLI accompanied the natriuresis induced by CTZ. This drug
probably inhibited Na transport not only in the distal, but also in the
proximal tubules: the fall in GFR suggests activation of glomerulo-
tubular feedback due to increased macula densa Na-delivery (probably
mediated by proximal CA-inhibition in view of the marked rise in
bicarbonate excretion). The rise in Vmax and CH2O support a proximal
effect of CTZ. In contrast, BFMT, probably inhibiting Na-transport in
the distal tubules only (fall in C1120, unchanged Vmax, GFR and
bicarbonate excretion), did not affect CLI. Conclusions: 1) CTZ in-
creases CLI due to a fall in proximal Li reabsorption related to
CA-inhibition; 2) Li is not reabsorbed in the thiazide-sensitive segment
of the distal tubule of the human kidney (no effect of BFMT on CLI); 3)
the data are in general agreement with the concept that CLI reflects Na
and H20 delivery from the proximal tubules.
Prenatal and presymptom diagnosis of adult polycystic kidney disease
using DNA markers on both sides of the gene. M.H. Breuning, S.T.
Reeders, T. Keith, A.L. van Es, G.J.B. van Ommen, P.L. Pearson,
Department of Human Genetics, State University Leiden, Leiden, The
Netherlands. The recently discovered genetic linkage between adult
polycystic kidney disease (PKDI) and the globin locus on chromosome
16 can be used for prenatal and presymptomatic diagnosis. However,
when this single marker is used, diagnostic errors are bound to occur in
4% of the cases due to recombination between the two loci during
meiosis. This problem does not arise when paired flanking markers are
used. We have isolated 7 new DNA fragments from the short arm of
chromosome 16. The inheritance of restriction fragment length poly-
morphisms was studied in 246 meioses in 9 families with PKD.
Independent three-point cross-overs between the various markers yield
a genetic map for the region around the PKDI gene (Fig.). The 7 new
DNA probes were all found to map to the other side of the PKDI gene,
relative to the alpha globin locus. Five markers are closely linked to the
PKD1 gene and can be used for early diagnosis. Together the DNA
polymorphisms bracketing the gene are informative in more than 80% of
the cases. The reliability of prenatal and presymptomatic diagnosis of
PKD in apparent non-recombinants (± 90% of the cases) is now more
than 99%.
telomere
Fig. Human chromosome 16 around the PKDI locus.
centromere
A nephritogenic role for anti-basement membrane and anti-tubular
brush border antibodies in experimental murine chronic graft-versus-host
disease. J.A. Bru,jn, P.C. W. Hogendoorn, W.E, Corver, L.J.C.M. vd
Broek, Ph.J. Hoedemaeker, G.J. Fleuren, Department of Pathology,
Leiden University Hospital, The Netherlands. The pathogenesis of
renal involvement was studied in murine chronic graft-versus-host
disease (GvHD), which is a model for human systemic lupus erythem-
atosus. GvHD was induced by 4 i.v. injections of lymphocytes from
DBA/2 donor mice into (C57BI lo><DBA/2)Fl hybrids at 3 to 4 day
intervals. Two weeks after the first injection, antibodies were found to
be deposited in the mesangium and along the glomerular basement
membrane (GBM) in a linear fashion, and the deposits changed to a
granular pattern after 6 to 8 weeks. At this stage, large electron-dense
complexes were present both subepithelially and subendothelially along
the GBM. Proteinuria increased up to 11,300 2,140 g/18 hr. Using
indirect immunofluorescence and enzyme-linked immunosorbent assay
(ELISA) in sera and kidney eluates, auto-antibodies were found di-
rected against both nuclear antigens and GBM component laminin, and
against renal tubular epithelial antigens (RTE). The specificity of the
anti-RTE antibodies was further characterized using absorption tech-
niques as well as immunoblotting. Injection of affinity-purified anti-RTE
antibodies from GvHD-serum led to the induction of immune complex
glomerulonephritis and proteinuria. The early linear immunofluores-
cence pattern seems to be caused by glomerular binding of anti-GBM
antibodies. Electron-dense complex formation in later stages results
from the superimposed deposition of anti-RTE antibodies. Similar
findings were recently described for Heymann nephritis in the rat, a
model for human membranous nephropathy.
Unilateral renal parenchymal disease with contralateral renal artery
stenosis of the fibromuscular dysplasia type: UPCRAS-syndrome. P.E. de
Jong, D de Zeeuw, J.D. Elema, G.K. van der Hem, University
Hospital, Groningen, The Netherlands. Hypertension with a unilateral
small kidney generally is caused by renal artery stenosis (RAS), a
congenital or a urological cause. During the last 6 years we observed 4
female patients (21 to 40 years old) referred for hypertension with a
unilateral small kidney, who appeared to have a severe RAS at the
contralateral side with a normal size of the kidney at that side. The
cause of the shrinkage was: a) renal dysplasia with reflux; b) hydrone-
phrosis and megaureter with an ectopic ureter orificium; and c) renal
hypoplasia. The fourth patient had experienced a blunt flank trauma
causing a hematoma in the upper lobe of one kidney. The contralateral
RAS in all 4 patients was due to fibromuscular dysplasia of the main
artery with extension into the branches. In 3 cases renal venous renin
values from the poststenotic kidney were increased above arterial
values, whereas elevated values from the smaller kidney were found in
2 patients. Thus far, 3 patients underwent ex vivo surgical repair of the
stenotic lesions, whereas the opposite kidney remained untouched.
Blood pressure normalized in all 3 cases. Although review of the
literature revealed evidence for more of such patients, it has not been
recognized as a distinct clinical entity. The combination of renal
parenchymal disease at one side and fibromuscular dysplasia contralat-
erally may have been coincidental. We however argue that the relative
frequent occurrence suggests the existence of a distinct syndrome. It
seems important to recognize this misleading syndrome to prevent
antihypertensive treatment modes such as nephrectomy of the
shrunken kidney (as in 1 of our cases) or ACE-inhibitors with a
deleterious effect on the poststenotic (and thus overall) kidney function,
as happened in all our patients.
Does the "protein-effect" on renal function in single kidney rats depend
on the age at nephrectomy? M.H. de Keijzer, A.P. Provoost, Depart-
ment of Pediatric Surgery, Erasmus University, Rotterdam, The Neth-
erlands. Following removal of one kidney, the remaining one undergoes
a rapid and marked increase in both size and function. Previous studies
in infant rats unilaterally nephrectomized at 4 weeks of age (UNX-4)
have indicated that after a period of hyperfiltration, the GFR will
decline. This process is preceded by severe proteinuria (UV). Further-
more, the amount of dietary protein had marked effects on the length of
the period of stable GFR, the level of U,V and the rate of fall in GFR.
Recently, we have investigated the GFR and U,V of male, adult rats
unilaterally nephrectomized at the age of 15 weeks (UNX-15), fed diets
containing 12%, 24%, or 36% protein. The GFR, as 51Cr-EDTA plasma
I I I I I I I I
alpha globin PKD 1 24-1/327 090 41-1 133 3-15 36-1
558 Abstracts
clearance, and U,,V were determined every 12 weeks. The Table
summarizes data (mean SD) obtained 24 and 72 weeks after UNX.
24 Weeks
GFR UV
mi/mm mg/day
72 Weeks
GFR
mi/mm
U,V
mg/day
12% UNX-4 1.52 0.17 29 9 1.43 0.19 90 40
UNX-15 1.47 0.13 34 18 1.07 0.23a 86
24% UNX-4 1.67 0.13 76 27 1.18 0.29 249 66
UNX-15 1.69 0.13 64 15 1.15 0.27 144 61
36% UNX-4 1.70 0.17 202 64 0.66 0.34 277 109
UNX-15 1.74±0.13 gQ45a 1.13±0.45a 104±48a
a P < 0.05 vs. UNX-4
The data indicate that at week 24, the age of the rat at the time of UNX
had no effect on the level of the GFR on the various diets. The same was
true for the U,V, except for rats on the 36% protein diet. In that case,
the U,V of the UNX-l5 rats was less than that of UNX-4. At week 72,
the GFR of UNX-4 rats is inversely related to the protein intake, that is,
the highest GFR on 12% and the lowest on 36% protein. In contrast, the
GFR of UNX-15 rats on the 3 diets is not different. At week 72, the U,,V
of UNX-15 on the 24% and 36% protein has increased less than that of
UNX-4 rats. We conclude that in rats UNX, irrespective of age, leads
to proteinuria and loss of GFR. In contrast to UNX-4, dietary protein
does not influence the rate of decrease in GFR or in U,V of UNX-1S
rats. Thus, this long-term "protein effect" after UNX in male rats
appears to be age-dependent.
An open study of the safety and efficacy of multiple doses of recombi-
nant-human erythropoletin in end—stage renal disease (pre-dialysis) pa-
tients. L.A.M. Frenken, R. Verberckmoes, H.E. Sluiter, G. SchrUver,
P. Michielsen, R.A.P. Koene, Department of Medicine, Division of
Nephrology, University Hospital, University of Nijmegen, The Neth-
erlands, and University Hospital Gasthuisberg, University of Leuven,
Belgium. The anemia of chronic kidney failure can be corrected with
recombinant human erythropoietin (rHuEPO) in patients who are
undergoing hemodialysis. In a two center study, we administered
rHuEPO three times a week intravenously over an eight week period to
determine the safety and efficacy of rHuEPO in pre-dialysis end-stage
renal disease patients. The trial included 24 patients who were ran-
domly allocated to three dosage groups containing 8 patients each. Dose
levels were 50 (Group I), 100 (Group II), and 150 (Group III) units per
kilogram of body weight (U/kg). The mean (± SD) age of the patients
was 49.9 14.1 years. The main results are given in the table. (MAP =
mean arterial pressure)
Hematocrit
liter/liter
Reticulocytes
x 10 '2/liter
Creatinine
pmol/liter
M.A.P.
mm Hg
Group I
Baseline 0.29 0.01 0.08 0.01 723 262 99 10
8th week 0.36 0.04a 0.08 0.03 780 350 98 9
Group II
Baseline 0.25 0.04 0.04 0.02 767 257 105 II
8th week 0.37 0.06 0.09 0.O4 790 244 113 9
Group HI
Baseline 0.26 0.03 0,06 0.06 724 248 107 23
8th week 0.39 0.03k 0.20 0.04 696 187 109 24
Means SD are given, a P < 0.02 for difference vs. baseline
The mean serum ferritin levels showed a significant reduction in all
groups. Thrombocyte counts rose significantly in groups II and III,
reaching a maximum at week 4 and decreasing thereafter. There was no
significant change in the mean total number of antihypertensive drugs
administered. No important adverse effects occurred. All patients
reported a great improvement in well-being. In conclusion, administra-
tion of rHuEPO corrected the anemia in pre-dialysis patients without
untoward effects on renal function and blood pressure during this initial
treatment period.
Enhanced natriuretic effect of atrial natriuretic factor (ANF) durIng
mineralocorticoid escape. C.A. Gaillard, H.A. Koomans, T.J. Rabelink,
E.J. Dorhout Mees, Department of Nephrology, University of Utrecht,
The Netherlands. We studied the renal response to ANF (25 ,.cg bolus
followed by a one hour infusion 0.02 p.g/kg. mm) in 7 normal subjects
on a 170 mmol Na/100 mmol K diet, before and after 10 days of
9a-fludrocortisone acetate 0.5 mg b.i.d. Renal sodium handling was
analyzed using lithium and maximal free water clearance methods.
Escape was accompanied by a rise in mean arterial pressure (95 9 to
109 8 mm Hg), inulin clearance (Ci,,, table), body weight (76.6 13.3
to 78.2 12.7 kg) and plasma ANF (9 6 to 24 11 pmol/Iiter). ANF
infusion raised GFR comparably before and after escape, but the
natriuretic effect was much larger after escape and was accompanied by
some kaliuresis. "Diluting segment solute delivery" (CR + Cc1/C1)
and fractional lithium excretion (FELl) showed a greater ANF-induced
increase during escape vs. control, whereas CH2OI(CH2O + Cci), an
approximation of diluting segment reabsorption, was more suppressed
during escape. These results suggest that not only a rise in plasma ANF,
but also increased renal sensitivity to ANF is involved in mineralocor-
ticoid escape. We suggest that the elevated blood pressure and thus
renal perfusion presiire is responsible for this effect.
Control Fludrocortisone
Baseline ANF Baseline ANF
C1,, ml/min 124 9 138 lOa
CPAR mI/mm 670 55 645 59
UNaV j.unol/min 248 48 630 l24
U,V p.mol/min 216 31 543 ll1
UKV i.unol/min 123 11 107 14
Urine flow mI/mm 18 2 23 2
Uosmoi mOs,n/kg 61 4 75 6
(CH2O+ C1)/C11,% 12.7 0,7 15.6 l.2a
CH2O/(CH2O + C1) % 86.8 1.1 76.7 2.8a
FELl % 28.9 1.0 32.3 l,Sa
137 7
655 87
366 34
247 27
57 8
25 1
47 4
16.8 0.5
89.6 1.3
443 2.4
152 7
680 80
1294 278k
1062 227
112 1438 378 8
24.8 2.o
74.2 3.6a
54,5 3.0k
a P < 0,05
Autoantibudies against myeloid lysosomal enzymes: A novel class of
autoantibodles associated with vasculitic syndromes. R. Goldschmeding,
G.E. van der Schoot, J. W. Cohen Tervaert, D. 1'. Mason, A.E.G.Kr.
von dem Borne, C.G.M. Kallenberg, Central Laboratory of the Neth-
erlands Red Cross Blood Transfusion Service, Laboratory of Experi-
mental and Clinical immunology, University of Amsterdam, Amster-
dam, The Netherlands, Department of Haematology, John Radcliffe
Hospital, University of Oxford, United Kingdom, and Department of
Clinical immunology, University Hospital, Groningen, The Nether-
lands. The anti-neutrophil cytoplasmic autoantibodies (ANCA or
ACPA) which are highly specific and very sensitive for active
Wegener's granulomatosis (WG), react in a characteristic staining
pattern with ethanol fixed, cytospinned neutrophils and monocytes
(ANCA immunofluorescence test). At routine investigation of patient
sera, however, not only positive (i.e. typical "WG ANCA") or nega-
tive, but also "atypical" staining patterns can be observed. We now
have obtained evidence that the typical WG-ANCA are directed against
a previously unidentified serine-protease of 29 kD, which co-purifies
with the azurophilic granules (i.e. the primary lysosomes) of normal
human neutrophils, and that at least some of the patient sera that give
atypical staining, contain autoantibodies against myeloperoxidase
(MPO) and neutrophil elastase, two other myeloid lysosomal enzymes.
Sera sent to our laboratory for routine ANCA-testing from 91 patients
suspected of vasculitis, were selected on the basis of their staining
pattern in the ANCA immunofluorescence test. The antigenic speci-
ficity of these 91 sera was analyzed in "sandwich" ELISA's with
mouse monoclonal antibodies (McAb's) against different constituents of
myeloid lysosomes. The catching McAb's used were NPS7 (anti-
neutrophil elastase, courtesy Dr. D. Mason, Oxford, UK), a McAb
against MPO (CLB), and 12.8 (a McAB against the 29 kD WG ANCA
antigen which was recently developed in our laboratory). Normal
mouse serum served as a negative control. All of the 41 scm positive for
WG-ANCA by immunofluorescence, but none of the other 50 scm
bound specifically to the caught 29 kD-antigen. Seventeen of the latter
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sera showed an atypical staining pattern. One of these 17 scm reacted
specifically with caught neutrophil elastase, and 7 with caught MPO,
whereas the 41 WG ANCA sera were negative in these assays. For 12
of the 41 WG-ANCA sera, and for all of the anti-MPO and anti-elastase
sera, the specificity of the respective autoantibodies was confirmed by
immunoprecipitation from a '251-labeled preparation of proteins ex-
tracted from neutrophil azurophilic granules. The ANCA of patients
with active Wegener's granulomatosis thus represent only one speci-
ficity from a whole novel class of autoantibodies against myeloid
lysosomal enzymes which appear to be associated with vasculitic
syndromes. The clinical significance of anti-myeloperoxidase and anti-
elastase is presently under investigation.
Left renal vein entrapment syndrome: A possible cause of hematuria in
childhood. J.J.E. Hendriks, C.H. Schröder, S.P. StrUk, J.D.M. de
Vries, L.A.H. Monnens, Departments of Pediatrics, Radiology and
Urology, St. Radboud Hospital, University of Nijmegen, The Nether-
lands. Gross hematuria in childhood is an alarming symptom, with a
rather extensive differential diagnosis. The absence of erythrocyte casts
or dysmorphous erythrocytes in the urinary sediment indicates a
non-glomerular origin. If the hematuria is accompanied by abdominal or
loin pain, a left renal vein entrapment syndrome (LRVES) has to be
considered. Diagnosis is strongly suggested by ultrasonography (US).
In supine or erect position the left renal vein (LRV) is then entrapped
between the aorta posteriorly and the superior mesenteric artery
anteriorly. Entrapment is defined as a 50% or greater narrowing of the
lumen of the LRV anterior to the aorta. Three children with LRVES
diagnosed in our department will be presented. Twenty normal children
were also investigated by us as control. In this control group a spectrum
of normal caliber to LRV compression was observed, a finding that is
also described in the literature. That the LRVES, however, is real is
proven by studies in which pull back pressure gradients were measured
in the LRV, LRV hypertension was observed. The finding of left-sided
blood loss on cystoscopy provides the definite argument. Bleeding is
thought to be caused by minute ruptures of the thin-walled veins of the
collecting system or renal fornix. With respect to prognosis only limited
data are available. A benign course is supposed. Aggressive therapy
like renocaval reimplantation is therefore seldom necessary. In conclu-
sion, the LRVES should not be overlooked in the diagnostic approach
of children with macroscopic hematuna and abdominal or loin pain. The
finding of isomorphous erythrocytes in the urinary sediment and a more
than 50% narrowing of the LRV on US can support the diagnosis.
Cystoscopy a chaud contributes to the definite diagnosis.
Chronic serum sickness (CSS) induced by bovine serum albumin
(BSA), human IgG (HuIgG), or human 1gM (HuIgM): The type of antigen(AG) determines localization found in the rat glomerulus. P.C.W.
Hogendoorn, E.B.L. van Dorst, M.R. Daha, G.J. Fleuren, Department
of Pathology and Nephrology, University of Leiden, Leiden, The
Netherlands. CSS was induced in three groups of Wistar rats by
immunization with BSA, molecular weight (MW) 66 kD (I), HuIgG,
MW 155 kD (II), or HuIgM, MW 900 kD (III), suspended in Freund's
adjuvant, followed by repeated i.p. injections. Renal tissue obtained 4,
5, 6, and 7 weeks after the start of the i.p. administrations was examined
by light (LM), immunofluorescence and electron microscopy. Protein-
uria was monitored weekly by measuring 24 hr urine, and the level of
the evoked immunerespons was measured by ELISA. All animals in
group I and II developed a progressive disease characterized by initial
deposition of AG and rat Ig in the mesangium followed by the
appearance of at first subendothelial and later subepithelial deposits.
This change in deposition pattern was associated with the onset of
massive proteinuria, reaching maximum levels of 450 mg/24 hr in group
I and 700 mg/24 hr in group H. Group III showed only mesangial
deposits of human 1gM and rat Ig without the development of protein-
uria. Group Land III showed minimal abnormalities by LM. In contrast,
associated with the long lasting phase of subendothelially-localized
immune aggregates in group II, transient but severe influx of granulo-
cytes was shown in glomeruli with the development of diffuse prolifer-
ative glomerulonephritis. No differences in height and type of im-
munerespons against the used AG were found. We conclude that the
type of glomerular pathology during CSS is dependent upon the
characteristics of the AG used for the induction of the disease. Among
these, physicochemical properties such as molecular weight and/or
shape seem to be mainly important with respect to the site of localiza-
tion in the glomerulus.
Mechanism of ACE-inhibition (ACEi) induced changes on '231-hippur-
ate renography (RE) in the two-kidney, one clip (2K-iC) hypertensive
dog. G.J. Jonker, D. de Zeeuw, R.M. Huisman, D.A. Piers, H.
Beekhuis, G.K. van der Hem, University Hospital, Groningen, The
Netherlands. ACEi improves the sensitivity of '231-hippurate RE for the
detection of a unilateral renal artery stenosis (RAS) in the dog by
delaying the excretion of the tracer on the stenotic side. To test the
mechanism(s) of these changes we analyzed (apart from the RE's) the
changes in renal function more accurately in the conscious, chronically-
instrumented 2K-1C dog by measuring urine flow (UV), renal blood
flow (RBF), and glomerular filtration rate (GFR) and effective renal
plasma flow (ERPF; measured with constant infusion of 1251-iothalam-
ate and '311-hippurate, respectively) of both kidneys separately before
and after ACEi. Experiments were performed 2 weeks after induction
of a mild unilateral RAS (25 to 35% reduction of RBF). After a 2 hour
equilibration (upon infusion of 250 mI/hr glucose 5%) three 20 mm
control measurements were performed, followed by three 20 mm
periods after 10 mg enalaprilic acid i.v. Urine was collected through a
newly-developed implanted catheter device, permitting a separate urine
collection from the kidneys during the experiments only. One week
later the experiments were repeated. The results (mean SEM, ap <
0.05 compared with ACEi) of 8 experiments in 4 dogs are:
Stenotic side Non-stenotic side
Control +ACEi Control +ACEi
GFR mI/mm
ERPF mi/mm
FF GFR/ERPF
UV mI/mm
RBF mI/mm
39 5
111 13
0.35 0.0219 4
191 19
7 3
34 l7
0.25 0.03a
1 0.4a
233 30
49 5
128 15
0.38 0.01
28 7
ND
53 4
176 l4
0.30 o.ol
41 9
ND
Thus, ACEi caused a striking reduction of urine flow, GFR and ERPF
at the stenotic side, whereas RE at the same time showed delayed
excretion and accumulation of tracer at the stenotic side. The ERPF
data dissociate with the RBF data at the stenotic side. These results
suggest that the alterations induced by ACEi on hippurate RE may be
due to nearly halting of urine flow at the stenotic side.
Long-term results of controlled cyclosporine conversion at 3 months
after renal transplantation. A.M.M. Kootte, L.M. Lensen, J.H. van
Bockel, L.A. van Es, L.C, Paul, Department of Nephrology and
Surgery, University Hospital Leiden, Leiden, The Netherlands. The
long-term results of patients who underwent elective conversion of
cyclosporin A (CsA) to azathioprine (Aza) at 3 months following
transplantation and those who remained on continuous CsA therapy
were evaluated in a prospective study of 66 renal transplant patients
who had been randomly assigned to each treatment group. The start
point of the study was thus at 3 months post-transplant; no differences
in the three-year patient and graft survival were found, and were 97%
and 97% in the converted group and 100% and 94% in the non-
converted group, respectively. The incidence of one or more anti-
rejection treatments did not differ between the two groups at 3 to 12
months (16% vs. 17%) or after 12 months (12% vs. 9%). The incidence
of hypertension was 79% to 100% in the group on continuous CsA
therapy versus 50 to 58% in the converted patients at different time
intervals. The degree of proteinuria in the 2 groups was not different at
3 and 12 months. At 24 and 36 months the proteinuria (g/24 hr) was
higher in the converted group (0.51 0.18 and 0.53 0.13; mean
sEM) versus the CsA group (0.15 0.04 and 0.21 0.09). At 3 years,
the mean creatinine clearance for the patients converted to Aza was
higher than that found for the continuous CsA-treated patients (67 8
and 59 6 mI/mm; mean 5EM). This study shows that early CsA
conversion to Aza gives a better 3-year graft function compared to
continuous CsA therapy. This may be attributable to the long-term
immunosuppressive properties of CsA given for a relatively short time
period, as well as to a reduction of late CsA nephrotoxicity.
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The value of ACE inhibition (ACEi) in radionuclide evaluation of
unilateral renal artery stenosis (RAS). T.K. Kremer Hovinga, P.E. de
Jong, D.A. Piers, H. Beekhuis, G.K. van der Hem, D. de Zeeuw,
University Hospital, Groningen, The Netherlands. No consensus has
been reached with regard to the optimal diagnostic procedure for RAS
in humans. Radionuclide investigations before and during ACE looks
promising for this purpose. To further evaluate this, 15 patients with
persistent hypertension and angiographically significant unilateral RAS
were studied using '231-hippuran (hipp), mTcDTPA renography(DTPA) and mTcDMSA scintigraphy (DMSA) before and after at
least two days of treatment with enalapril 10 mg bid. Evaluation was
done both visually and quantitatively, the latter by calculation of
asymmetrical function (discriminant ratio R) in the renograms and by
relative uptake in the scintigrams. In this selected group of patients,
abnormal radioisotope studies compatible with renal artery stenosis
were found frequently in the baseline situation (hipp 87%, DTPA 60%,
DMSA 60%). During ACE inhibition these percentages increased for all
three methods (93%, 87%, 80%, respectively). In 4 out of 5 patients with
initially a relatively normal R value (hipp), this parameter decreased
from 0.68 to 0.35 during ACE. Similar findings were observed with
DTPA renography. Substantial decrease in relative DMSA uptake on
the stenotic side was seen in most patients, who showed an uptake of
more than 10% initially (N = 12, mean from 37% to 23%). In some
segmental defects were seen after ACEi. Overall MAP decreased from
126 to 107 mm Hg during ACEi. Overall renal function (creatinine
clearance) was well maintained (mean 69 mllmin/t .73 m2 before and 65
mI/mm/I .73 m2 during ACEi), although in a subgroup of lowest initial
function a more marked fall was observed. In conclusion, the different
renograms appear reasonably comparable in their sensitivity to detect
RAS. After ACE all methods showed a higher detection rate, particu-
larly in the situation of borderline abnormalities before ACEi. DMSA
scintigraphy can be helpful in case of segmental stenosis.
The effect of insulin on proximal and distal tubular sodium absorption.
A.J. Luik, R.J. Heine, W.H.L. Hackeng, A.J,M. Donker, Department
of Internal Medicine, Free University, Amsterdam, and Department of
Endocrinology, Bergweg Hospital, Rotterdam, The Netherlands. It is
known that insulin can exert a sodium retaining effect. This may play a
role in the pathogenesis of hypertension in patients with hyperin-
sulinemia, and in the appearance of insulin edema. Micropuncture
studies in dogs and clamp studies in man suggest an effect of insulin on
the distal tubule. We studied the effect of insulin on the fractional
sodium, lithium, osmolality, 3rmicroglobulin, calcium, phosphate, uric
acid, potassium, and creatinine clearances (CNa, CLI, C,o, Cpm, Cca,
Ck, Curie acid' C, Ccr) during an euglycemic clamp and maximal water
diuresis. Eight healthy volunteers, aged 23 to 29 years, were studied
during seven hours. Insulin concentrations were increased stepwise
from 11 to 1149 mU/liter. Blood glucose concentration was kept on the
basal fasting value. Fractional sodium reabsorption in the proximal and
distal tubule was calculated by means of maximal urine flow and Cu20
during water diuresis, and by means of CLI. CLI is known to be the most
reliable method for measuring proximal sodium reabsorption. For
statistical analysis we used the Wilcoxon's signed rank test. Linear
correlation coefficients were calculated, Fractional sodium clearance
(± SD) declined from 1.60 (0.49) to 1.09 (0.33) % (P <0.1). Fractional
proximal sodium reabsorption declined from 83.44 to 74.57% (P C 0.05)
calculated with the CLI (r =
—0.617; P C 0.001). Fractional distal
sodium reabsorption increased from 14.96 to 24.34% (P C 0.02; r =
0.630, P C 0.001). Comparable results were obtained using the urine
flow and C20 methods. Fractional Cca increased from 1.92 to 4.25% (P
C 0.02; r = 0.625; P C 0.001). Fractional C varied unpredictable
between 12.50 and 10.15%. There was a marked increase in fractional
from 0.02 to 2.55% (P < 0.02; r 0.434, P C 0.001), Fractional CK
decreased from 16.49 to 6.56% (P C 0.02; r = —0.621, P C 0.001).
Fractional Curie acid, fractional Cci and Ccr did not change significantly.
Aldosterone and parathyroid hormone levels did not change either.
From these data we conclude that insulin has a depressive effect on
sodium and sodium-associated reabsorption in the proximal tubule.
However, insulin enhances the sodium reabsorption in the distal tubule.
These effects are probably a direct effect of insulin on the nephron,
considering earlier studies with dogs in which a unilateral fall in urinary
sodium excretion was seen after insulin infusion directly into one renal
artery. Also the presence of insulin receptors with varying densities on
isolated rabbit nephron segments supports such a direct effect.
Renal function three months after discontinuation of cyclosporlne in
patients with multiple sclerosis. JO. Mispelblom Beyer, A.J.M. Donker,
J.C. Koetsier, Diaconessenhuis/Mariastichting, Haarlem, and Free
University Hospital, Amsterdam, The Netherlands. After a 2 year,
double-blind controlled trial of cyclosporine (C5A) against placebo (P)
in patients who have multiple sclerosis, which was conducted at 2
centers, renal function of 23 selected patients in one center was
evaluated 3 months after withdrawal of CsA or P. Glomerular ifitration
rate (GFR; mI/mm/I .73 m2) was measured with '25I-thalamate, and
effective renal plasma flow (ERPF; mI/mm/I .73 m2) with '"I-hippurate.
In addition, the effect of a low dose dopamine (D; 2 jig/kg body wt per
mm) on GFR and ERPF was studied. At the time of the studies, it was
still unknown to the investigators to which group patients had been
allocated. CsA-treated patients (N = 12) had started with 10 mg CsA/kg
body wt per day and had received a mean dose of 5 mg CsA/kg body wt
per day during the last year. Whole blood CsA trough levels had been
kept below 600 ng/ml.
UFR GFR+D ERPF ERPF+D
P 102±10 102±13 426±53 572±90
CsA 78 l6 75 l5 341 78 382 8?
Wilcoxon rank sum test; aP C 0.01 CsA vs. P.
As shown in the table, mean (± sD) GFR and ERPF were significantly
lower in the CsA-treated patients compared to the control group.
During infusion of a low dose dopamine the differences persisted.
SERPF was significantly lower in the CsA-treated group (P C 0.01).
Retrospectively, we studied the course of the serum creatinine concen-
tration in both groups. In the placebo-treated group mean serum
creatinine concentration was 75 j.tmol/liter at the start of the study, 75
jimol/liter at 24 months and 78 jimol/liter at 27 months. The values of
the CsA-treated patients were 79, 113 (P C 0.01) and 93 jimol/liter (P C
0.01), respectively. The value at 27 months was still significantly higher
than the baseline value (P C 0.05). Mean arterial pressure in the
placebo-treated patients was 101 11 and 94 10 mm Hg at 0 and 24
months, respectively, being 99 9 and 106 10 mm Hg (P C 0.05) in
the CsA-treated group. Thus, a relatively low dose of CsA for 2 years
led to renal impairment, still present 3 months after discontinuation of
the drug. As no beneficial effect of this dose of CsA was seen upon the
progression of the disease and higher doses induce more renal impair-
ment, we cannot recommend the routine use of CsA in multiple
sclerosis.
Indomethacin-induced lithium reabsorption: Support for lithium reab-
sorption beyond the proximal tubules In humans. A.J. Rabelink, H.A.
Koomans, W.H. Boer, E.J. Dorhout Mees, Department of Nephrology;
Utrecht, The Netherlands. We examined the effect of semi-acute
indomethacin (Indo) (4 x 50 mg orally during preceding 18 hr) on renal
function parameters, including fractional lithium reabsorption (FRLI) in
7 healthy subjects during a 200 mmol and a 40 mmol sodium diet.
Studies were carried out during maximal water diuresis. During the
sodium-rich diet Indo raised minimal urine osmolality from 61 Ito 72
2 mOsm/kg (P C 0.05), and during the sodium-restricted diet from 55
3 to 93 6 mOsm/kg (P < 0.01). Indo reduced maximal free-water
clearance significantly only during the low sodium diet, and had no
consistent effect on inulin clearance and the fractional excretion of
sodium. No changes in fractional uric acid and phosphate reabsorption,
alleged qualitative markers of proximal tubular solute handling, were
observed. Fractional "distal" sodium reabsorption (CH2o/Cj2 + Cci)
did not change as well. Nevertheless, FRLI rose substantially, from 71
2 to 75 2%(P <0.01) and from 75 2 to 81 2%(P <0.01) during
high and low sodium diet, respectively. During either diet Indo caused
a significant reduction of 24-hr urine PGE2 excretion. Since interference
with renal prostaglandin synthesis is not supposed to influence proximal
tubular sodium reabsorption, the rise in lithium reabsorption occurred
beyond this nephron level, presumably in Henle's loop. Clearly, the
FRLI cannot be used unconditionally as a quantitative marker of
proximal tubular sodium reabsorption in humans.
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Anti-GBM nephritis in beige mice with a deficiency of granulocytic,
neutral proteinases. G. Schrijver, J. Schalkwijk, J. C.M. Robben,
K.J.M. Assmann, R.A.P. Koene, Department of Medicine, Divisions of
Nephrology and Rheumatology, and Department of Pathology, Uni-
versity Hospital, NUmegen, The Netherlands. Anti-glomerular base-
ment membrane (GBM) nephritis can be induced in mice by injection of
heterologous antibodies against mouse GBM. In previous experiments
we found that the induction of albuminuria and glomerular lesions in
this model can be prevented by depletion of PMNs, but not by depletion
of complement. In several studies reactive oxygen metabolites and
lysosomal proteinases produced by activated PMNs have been impli-
cated as agents contributing to the tissue damage. The role of the
neutral proteinases, elastase and cathepsin G, was examined by injec-
tion of rabbit anti-mouse GBM antiserum in beige mice (C57BL/6J,bgl
bg), which are congenitally deficient for these leukocytic proteinases.
Normal C57BL/6J,+/+ mice were used as controls. With doses of
antiserum varying from 1.4 to 22 mg of rabbit Ig, albuminuria in beige
mice was more than tenfold lower than in control mice. Only at the
highest dose of antiserum (22 mg) was the albuminuria in beige mice
slightly higher than in untreated beige mice. Histologically, in both
strains of mice a comparable influx of PMNs was found in the glomeruli
two hours after the administration of the antiserum. Despite the
absence of albuminuria in beige mice, electron microscopic studies of
glomeruli revealed damage of endothelial cells similar to that in the
control mice. In both strains PMNs were seen lying in close contact
with the GBM. In vitro experiments with granulocytes obtained from
peritoneal exudate of beige and control mice showed no differences in
superoxide production between the two strains. However, elastase and
cathepsin 0 activity from granulocyte extracts of beige mice was only
10 to 15% of the activity in extracts of control mice. GBM degradation
in vitro by granulocyte extracts of beige mice was 70% lower than the
GBM degradation by similar extracts from control mice. These findings
show that in the early phase of anti-GBM nephritis in the mouse the
granulocytic neutral proteinases (elastase and cathepsin 0) are respon-
sible for the glomerular damage and albuminuria.
Anti-glomerular basement membrane nephritis in two children with
Alport syndrome after renal transplantation. C.H. Schroder, L. v.d.
Heuvel, C.O.S. Savage, D. Menzel, L.A.H. Monnens, J.H. Veerkamp,
Departments of Pediatrics and Biochemistry, St. Radboud Hospital,
University of Nijmegen, Department of Pediatrics, University of Am-
sterdam, The Netherlands, and Royal Postgraduate Medical School,
London, United Kingdom. Alport syndrome is a metabolic disorder of
basement membrane collagen. A defective composition of the globular
(NC1) domain, in which the Goodpasture antigen resides, has been
made probable with studies using several antibodies against compo-
nents of this domain. Anti-glomerular basement membrane (anti-GBM)
nephritis in transplanted Alport patients has occasionally been re-
ported. Two children, aged 10 and 17 years, respectively, developed
rapidly progressive anti-GBM disease in their allografts 6 months after
transplantation. Both children lost their graft. After digestion of normal
GBM with collagenase and SDS-PAGE, one-dimensional immunoblot-
ting was performed with the sera of the two patients, a Goodpasture
serum, and a mouse monoclonal antibody (MCA-P1), directed against
the Goodpasture antigen. All sera showed the same banding pattern.
They reacted with bands at 54, 50, 48, 43, 28 and 26 kDa, indicating
reactivity with both monomers and dimers. Two-dimensional immuno-
blotting of collagenase-solubilized glomerular basement membrane
from controls (with a non-equilibrium pH gradient electrophoresis(NEPHGE) in the first dimension followed by 5 to 20% gradient
SDS-PAGE in the second dimension) with the sera of the two patients
showed the same spot pattern as that found for the Goodpasture serum
and the monoclonal antibody. With these experiments no differences
between Goodpasture antigen and the missing antigen of Alport syn-
drome could be demonstrated.
Functional characteristics of the peritoneal membrane in long duration
CAPD. D.G. Struijk, R.T. Krediet, G.C.M. Koomen, E.W. Boeschoten,
H.J. vd Rejjden, L. Arisz, Departments of Medicine and Clinical
Chemistry, Academic Medical Centre, Amsterdam, The Netherlands.
To investigate the long-term effects of CAPD on the characteristics of
the peritoneal membrane we examined 11 patients with a mean duration
on CAPD of 61 months (range 51 to 76) (LD) and compared them with
eleven patients who recently started CAPD (mean 1 month, range 0 to
2; RSP). The patients were matched for sex, age and causes of renal
failure. The maximal ultrafiltration capacity (MUC) was calculated by
linear regression between the drained volume of three different glucose
solutions during dwells of 4 hours, and the initial dialysate glucose
concentration. Mass transfer area coefficients (MTC) of solutes with a
molecular weight of 60 to 820000 were calculated for a 2 liter, 4 hr dwell
using glucose 1.36% dialysate. MUC of LD was 425 100 ml/4 hr and
of RSP 805 76 (P < 0.02). No differences were found in the MTC
values of urea, lactate, glucose, kanamycin, inulin, albumin, IgG and
a2-macroglobulin. MTC-creatinine (C) and MTC-p2-microglobulin
(/32m) were higher in the LD than the RSP group (12.5 1.2 vs. 8.5
0.7 mllmin, P < 0.02 and 0.95 0.09 vs. 0.63 0.05 mI/mm, P < 0.01).
We conclude that no functional deterioration of solute transport char-
acteristics of the peritoneal membrane occurs in LD on CAPD. The
higher MTC-C and MTC-132m are probably caused by the lower residual
renal function in LD, leading to higher serum levels and increased
peritoneal concentration gradients. The decrease in MUC in this case
control study confirms clinical observations and the results of a
previous retrospective investigation. As MTC-glucose was not in-
creased in LD a direct relationship between the lower MUC and the
peritoneal concentration gradient of glucose is unlikely. Other mecha-
nisms like lymphatic flow may also be important.
Measurement of lymphatic absorption in CAPD patients by intravenous
and intraperitoneal administration of inulin. D.G. Strusjk, R.T. Krediet,
G,C.M. Koomen, E.W. Boeschoten, H.J. vdRejden, L. Arisz, Depart-
ments of Medicine and Clinical Chemistry, Academic Medical Centre,
Amsterdam, The Netherlands. Lymphatic absorption from the perito-
neal cavity (LA) can be measured in CAPD patients by calculating the
disappearance rate of a macromolecular substance added to the dialy-
sate. Trapping of such a substance in the interstitial tissue could lead to
overestimation of the lymphatic flow. Another possibility to measure
LA is the comparison of the peritoneal transport between intravenous
(i.v.) and intraperitoneal (i.p.) administration of a solute with a lower
molecular weight. Seven CAPD patients were studied. Their age ranged
from 25 to 75 years (mean 51). The patients were examined on two
separate days during a 4 hours dwell, using 2 liters dialysate (Dianeal
1.36%). In the i.p. study inulin was added to the dialysate (5 g) and in
the i.v. study inulin (5 g) was given iv. 3 hours before the test. Mass
transfer area coefficients (MTC) were calculated for urea, creatinine,
glucose and inulin. There were no differences in the MTC of urea,
creatinine and glucose between the two tests. The MTC of inulin i.v.
was 2.2 0.2 mi/mm and of inulin i.p. was 3.7 0.1 (P <0.001, paired
t-test). As extensive trapping of inulin in the interstitial space is not
likely because of its molecular weight, the difference between the two
calculated MTC values of inulin (1.5 mI/mm) represents LA. A lym-
phatic flow of 1.5 mi/mm corresponds to the data obtained with
macromolecules, such as human albumin and autologous haemoglobin.
The renal handling of the pepsinogens A and C in man. R. W. ten Kate,
G. Pals, J.C. Pronk, A.J.M. Donker, A.W. Eriksson, S.G.M. Meuwis-
sen, Departments of Internal Medicine and Gastroenterology and
Institute of Human Genetics, Free University Hospital, Amsterdam,
The Netherlands. Pepsinogens (P) are low molecular weight (LMW)
proteins synthesized by the gastric mucosa. On biochemical and
immunological bases, P are divided in P group A (PGA) with a MW of
43,500 700 daltons, and P group C (PGC) with a MW of 40,000 900
daltons. Both PGA and PGC are negatively charged (p1 less than 5.0).
P are secreted into the gastric lumen but also into the systemic
circulation. We have studied the renal handling of PGA and PGC in
man. The average fractional excretion of PGA was 27.6% (range 4.4 to
73.9) in healthy volunteers (N = 21) and 37.9% (range 7.0 to 81.9) in
patients with chronic renal disease (GFR ranging from 9 to 130 mI/mm;
N = 18). The fractional excretion of PGC amounted to 1.0% (range 0.04
to 6.8) in healthy volunteers (N = 21) and increased to about 40% in
patients with a GFR below 40 mI/mm. From these results it was
concluded that both P are filtered. The difference in renal excretion
between PGA and PGC might be due to a low affinity—high capacity
(PGA) and a high affinity—low capacity (PGC) tubular reabsorption,
respectively. The high fractional excretion of PGA, and of PGC if GFR
<40 mI/mm, implies an unexpectedly high glomerular sieving of these
LMW proteins. We therefore assessed the glomerular sieving coeffi-
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cient (GSC) of both isozymogens by measuring the A-V differences
over the kidney in patients undergoing an elective heart catheterization
(N = 9). In contrast to transferrin, albumin and IgG, high GSC were
found for PGA and PGC, which were comparable to the GSC of
flrmicroglobulin. P possess a positively charged activation peptide
(MW 3200 daltons) located at the surface of the molecule. This might
explain the high GSC in analogy to the binding of net anionic antigens
with discrete positive regions to the glomcrular polyanion (Batsford et
al: (Abstract) Xth mt Congr Nephrol London, July 1987, p. 313).
In accord with this hypothesis is the previously made observation
that in dogs intravenously injected pepsinogen was easily recovered
from the urine while intravenously injected pepsin (= pepsinogen minus
activation peptide) was not (Mirsky et al: J Clin Lab Invest 27:818—24,
1948). Thus, beside MW, radius and net charge, the distribution of
charge over the surface of the molecule seems to be a major determi-
nant of the sieving of LMW proteins through the glomerular basement
membrane.
Effect of atrial natriuretic peptide (ANP) on the superficial proximal
tubule and loop of Henle. Anja van de Stolpe, Kristina Blouch, Rex L.
Jamison, Departments of Medicine, Stanford University, Stanford,
Cal jfornia, and University of Rochester, Rochester, New York, USA.
To determine if ANP inhibits reabsorption in the proximal tubule and
Henle's loop, rats were anesthetized and prepared for recollection
micropuneture of late proximal (LP) and early distal (ED) tubules.
Experimental (E, N = 11) rats received ANP, 0.8 jzgfkg body wt prime
and 0.1 /kgfmin per kg body wt infusion; control (C, N = 12) rats
received the vehicle only. Each group was studied before (Period 1) and
during (11) ANP or vehicle, respectively. Results: GFR Qd/min),
SNGFR (nllmin), tubule fluid Na concentration (TFNa, mEq/liter),
fractional Na delivery (TF/P (Na/inulin) x 100, %) and Na excretion
(UNaV, tEq/min per g k wt), were (means):
[TF/P(NaJ
OFR SNGFR
TFNa
ED
in)x 1001
LP ED UNaV
C I 1351 40 45 50 4.2 0.16
C II 1213 43 47 57 0.33
E 1 1134 41 41 53 5.5 0.19
E II 1083 45 58b 74b,c 1005.1 2ol
a p C o,o5, P < 0.01, period II vs. I; P < 0.05, ElI vs. CII
OFR and SNGFR did not change significantly. After ANP UNaV
increased 10-fold and K, Ca, Mg and 1-120 excretion 3-fold. Comparing
E II to C 11, fractional Na delivery to the LP tubule increased
significantly after ANP. Results were similar for K, Mg, Ca and 1120.
TFNa and TFMg at the ED tubule rose after ANP. Fractional delivery
of Na, Ca, Mg and 1120 to the ED tubule increased more after ANP
than in control rats. These findings suggest that ANP (1) reduces
reabsorption in the superficial proximal tubule and (2) impairs normal
reduction of Na and Mg concentration by Henle's loop.
Lymphocytic expression of renal brush border (SB) hydrolases.
E.H.G. van Leer, P. Moullier, P. Ronco, P. Verroust, Department of
Pathology, University of Leiden, The Netherlands and HOpital Tenon,
Paris, France. Leukocytes and glomerular cells of various species
share a number of membrane bound antigens such as Thy- 1 and
complement receptors. Circulating antibodies to these antigens have
been shown to have nephritogenic potential, and hypothetically,
nephritogenic antibodies could have a direct effect on the immune
system, possibly affecting the course of glomerulonephritis. To test this
hypothesis, we analyzed lymphocyte expression of six renal brush
border antigens primarily defined by monoclonal antibodies raised
against rat SB. A 90 kD (gp 90) glycoprotein, synthesized by proximal
tubule cells and glomeruli, was found on the surface of T and B cells in
the rat. This gp 90 was previously shown by us to serve as a target for
the formation of short-lived immune deposits in the glomerular capillary
wall in Heymann's nephritis. The other antigens including the 330 kD
protein also involved in Heymann's nephritis were not detectable on the
surface of lymphocytes. Immunocytochemical studies indicate that the
protein identified by immunoprecipitation from SB and lymphocytes
comigrate on SDS-PAGE, thus excluding cross reactivity. By a solid
phase immuno-depletion technique gp 90 was identified as dipeptidyl
peptidase type IV (DPP IV). Similar studies performed by us in rabbits
suggest that DPP IV has a similar distribution on renal SB, glomeruli
and lymphocytes. Studies on human lymphocytes by others suggest
that in man DPP IV activity may be present on T cells only. Based on
our studies it is conceivable that anti-gp 90 antibodies not only
participate in the pathogenesis of glomerulonephritis but also affect the
immune response.
Long-term prognostic significance of the reduction of proteinurla by
indomethacin (I) In patients with chronic glomerulonepbritis. Y.
Vanrenterghern, P. Michielsen, U.Z. Gasthuiberg, Leuven, Belgium.
It is well established that the degree of proteinuria correlates well with
the progression of chronic glomerulonephritis. The reduction of pro-
teinuria by I may therefore have a more than symptomatic significance.
We analyzed the long-term effect of reduction of proteinuria in 282
patients with chronic glomerulonephritis. Patients were classified as
"responders" (N = ISO) and "nonresponders" (N = 132) according to
whether or not the urinary protein excretion decreased by 50% or more
1 year after initiation of therapy. Age, blood pressure, Cc1 and
proteinuria were identical before the initiation of therapy. At 1 year
proteinuria was decreased from 4.4 g/day to 0.81 g/day in the respond-
ers and from 4.3 glday to 4 g/day in the nonresponders. In the
responders Cc1 was 91 mI/mm before and 92 mI/mm at 1 year, in the
nonresponders 91 mI/mm and 81.4 mI/mm at 1 year. Renal survival was
significantly different between the 2 groups (P C 0.001): at 10 years,
survival was 91% in the responders and 71% in the nonresponders.
Although this effect was most marked in the nephrotic patients (N =
125), a significant difference in survival was also seen in the non-
nephrotic patients (P C 0.03). Our findings indicate that the reduction of
proteinuria by I has an important prognostic value for the evolution of
renal function. Reduced mesangial overload and/or normalization of
serum lipid abnormalities may be one of the mechanisms by which
reduction of proteinuria protects the kidney in nephrotic patients. As
the effect is also seen in non-nephrotic patients (proteinuria before I was
only 1.7 g/day), a more fundamental effect on the underlying glomerular
injury is possible.
